Fig. 1From: Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinomaStudy population. The target population of this study comprised patients with advanced HCC pretreated with sorafenib and those who were considered as candidates for subsequent therapy and were included in study 1. Patients who died before the analysis were included in study 2Back to article page